⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23595739 | 1.00 | — | — | |
| SCHEMBL18239349 | 1.00 | — | — | |
| SCHEMBL12309751 | 0.98 | KMT2A (0.52) | — | |
| SCHEMBL13044935 | 0.98 | KMT2A (0.52) | — | |
| Hydrochloric Acid SCHEMBL10965326 | 0.98 | CA1 (0.48) | — | |
| Benzene SCHEMBL29051407 | 0.94 | CA1 (0.45) | — | |
| SCHEMBL19695675 | 0.93 | — | — | |
| Chlorobenzene SCHEMBL28579335 | 0.82 | MAPT (0.47) | — | |
| Fluorobenzene SCHEMBL28699414 | 0.82 | MCL1 (0.41) | — | |
| SCHEMBL28282310 | 0.76 | CA1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200253894-A1 | INTRANASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2020-08-13 | — | — | US | claimed |
| US-4051308-A | Process for polymerizing butadiene with cobalt complex, AlR3 and CS2 | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1977-09-27 | — | — | US | claimed |
| WO-2025111597-A1 | A TREATMENT FOR PATIENTS WITH MOOD DISORDERS USING N-ETHYL-2-(5-FLUORO-1H-INDOL-3-YL)- N-METHYLETHAN-1-AMINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | GILGAMESH PHARMACEUTICALS, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| US-20240415848-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANESTHESIOLOGICAL APPLICATIONS | FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT | 2024-12-19 | — | — | US | disclosed |
| EP-4337182-A1 | REDUCING SIDE EFFECTS OF NMDA RECEPTOR ANTAGONISTS | Seelos Therapeutics, Inc. (US) | 2024-03-20 | — | — | EP | disclosed |
| CN-116942646-A | R-ketamine liquid preparation and application thereof | 宜昌人福药业有限责任公司 | 2023-10-27 | — | — | CN | disclosed |
| WO-2023133554-A2 | MICROSPHERE FORMULATIONS COMPRISING KETAMINE AND METHODS FOR MAKING AND USING THE SAME | OAKWOOD LABORATORIES, LLC (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2022241315-A1 | REDUCING SIDE EFFECTS OF NMDA RECEPTOR ANTAGONISTS | SEELOS THERAPEUTICS, INC. (US) | 2022-11-17 | — | — | WO | disclosed |
| EP-3908571-A1 | KETAMINE DERIVATIVES AND COMPOSITIONS THEREOF | XWPharma Ltd. (KY) | 2021-11-17 | — | — | EP | disclosed |
| WO-2021134086-A1 | ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021121366-A1 | LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTS | ALAR PHARMACEUTICALS INC. (CN) | 2021-06-24 | — | — | WO | disclosed |
| US-7314936-B2 | Deazapurines and uses thereof | EISAI CO., LTD. (JP) | 2008-01-01 | — | — | US | disclosed |
| US-7314936-B2 | Deazapurines and uses thereof | EISAI CO., LTD. (JP) | 2008-01-01 | — | — | US | disclosed |
| WO-2007117180-A1 | AZAHETEROCYCLES, COMBINATORY LIBRARY, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION AND METHODS FOR THE PRODUCTION THEREOF | 'CHEMICAL DIVERSITY RESEARCH INSTITUTE' LTD. (RU) | 2007-10-18 | — | — | WO | disclosed |
| EP-0254313-A2 | Use of ketamine for the manufacturing of medicaments for prevention or reduction of the effects of stroke in a subject having increased risk for stroke | WARNER-LAMBERT COMPANY (US) | 1988-01-27 | — | — | EP | disclosed |
| US-4258160-A | BY USE OF A CATALYST COMPRISING A COBALT-CONTAINING COMPONENT, AN ALKYL ALUMINUM COMPONENT, AND CARBONYL SULFIDE | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
| US-4248988-A | CATALYST SYSTEM COMPRISING COBALT OR NICKEL COMPONENT, HYDROCARBYL ALUMINUM, AND HALOGENATED HYDROCARBON | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1981-02-03 | — | — | US | disclosed |
| US-4198496-A | COBALT COMPONENT, MAGNESIUM OR MANGANESE CHLORIDE, IODIDE OR CARBOXYLIC ACID SATL, ORGANOALUMINUM HALIDE AS CATALYST | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
| US-4051308-A | Process for polymerizing butadiene with cobalt complex, AlR3 and CS2 | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
| US-3993856-A | CATALYST OF COBALT COMPOUND, HYDRO- OR HYDROCARBYLALUMINUM DIHALIDE, AND CARBON DISULFIDE | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1976-11-23 | — | — | US | disclosed |